{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:12:30Z","timestamp":1790190750918,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.nmd.2016.09.020","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T21:02:03Z","timestamp":1475269323000},"page":"90-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Successful autologous haematopoietic stem cell transplantation for refractory myasthenia gravis \u2013 a case report"],"prefix":"10.1016","volume":"27","author":[{"given":"Irene","family":"H\u00e5kansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sandstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Askmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritva","family":"Pirskanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Piehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"H\u00e4gglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2016.09.020_bib0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.nmd.2016.09.020_bib0015","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/joim.12310","article-title":"The autoimmune spectrum of myasthenia gravis: a Swedish population-based study","volume":"277","author":"Fang","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.nmd.2016.09.020_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ana.10449","article-title":"\u201cRebooting\u201d the immune system with cyclophosphamide: taking risks for a \u201ccure\u201d?","volume":"53","author":"Lewis","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2016.09.020_bib0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1196\/annals.1405.033","article-title":"Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis","volume":"1132","author":"Drachman","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nmd.2016.09.020_bib0030","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archneurol.2009.28","article-title":"Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis","volume":"66","author":"Strober","year":"2009","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.nmd.2016.09.020_bib0035","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jamaneurol.2016.0113","article-title":"Myasthenia gravis treated with autologous hematopoietic stem cell transplantation","volume":"73","author":"Bryant","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nmd.2016.09.020_bib0040","first-page":"16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of theMyasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2016.09.020_bib0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1749-6632.2012.06812.x","article-title":"The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice","volume":"1274","author":"Burns","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nmd.2016.09.020_bib0050","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/mus.21053","article-title":"Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis","volume":"38","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2016.09.020_bib0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2016.09.020_bib0060","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.4049\/jimmunol.1002539","article-title":"Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis","volume":"186","author":"Gomez","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.nmd.2016.09.020_bib0065","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/jnnp-2013-307207","article-title":"Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience","volume":"85","author":"Burman","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2016.09.020_bib0070","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/jnnp-2013-306014","article-title":"Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP","volume":"85","author":"Press","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2016.09.020_bib0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/imj.12944","article-title":"The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders","volume":"46","author":"Rebeiro","year":"2016","journal-title":"Intern Med J"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616302954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616302954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:05:43Z","timestamp":1760774743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896616302954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0960896616302954"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2016.09.020","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful autologous haematopoietic stem cell transplantation for refractory myasthenia gravis \u2013 a case report","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2016.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}